AI-generated summary
The authors studied bone marrow stem cells from healthy rats and from ovariectomized rats with induced osteoporosis, cultured in vitro. They report that photobiomodulation therapy, alone or combined with oxytocin, increased the viability of osteoporotic-model cells, with mineralization and gene expression effects varying by stage of osteogenic induction. Findings come from a laboratory cell study, not from people.
- Who or what was studied
- Bone marrow mesenchymal stem cells harvested from healthy (sham) and ovariectomy-induced osteoporotic rats, cultured in vitro
- Limits stated in the abstract
- The study is an in vitro cell and animal-derived study, and the abstract does not report a human sample or the specific light wavelength used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.